Average Co-Inventor Count = 4.45
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (18 from 212 patents)
2. Merck Frosst Canada & Co. (7 from 76 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Bhi Limited Partnership (1 from 5 patents)
6. Merck Canada Inc. (40 patents)
27 patents:
1. 9051248 - Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
2. 7960409 - Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
3. 7943649 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
4. 7629467 - Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
5. 7442716 - 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
6. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
7. 6639077 - Tri-aryl-substituted-ethane PDE4 inhibitors
8. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors
9. 6316472 - Heterosubstituted pyridine derivatives as PDE 4 inhibitors
10. 6204275 - PDE IV inhibiting compounds, compositions and methods of treatment
11. 6200993 - Heterosubstituted pyridine derivatives as PDE4 inhibitors
12. 6180650 - Heterosubstituted pyridine derivatives as PDE 4 inhibitors
13. 5817700 - Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
14. 5389650 - (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
15. 5380850 - (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of